Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Cancer Treat Res ; 174: 237-248, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29435846

RESUMEN

In this chapter, we examine the demographics and risk factors in the population diagnosed with head and neck cancer (HNC), what challenges these patients face post-treatment and what the role of psychosocial support through clinical social work is in managing these stressors. While many forms of head and neck cancer found in the early stages have a high cure rate, the side effects of treatment for these cancers have major life-altering effects. Previously, the majority of those diagnosed with head and neck cancers were those who used excessive alcohol and tobacco, but the numbers are changing to include the human papillomavirus (HPV) as a major risk factor. Due to the behavioral risk factors that are often causes of head and neck cancers and the effects of treatment that often lend to psychosocial distress, the role of psychosocial intervention at time of diagnosis throughout the disease trajectory is essential for compliance with treatment and healthy coping post-treatment. Clinical social workers play an essential role within the multidisciplinary team of assessment and interventions for managing patient's psychosocial distress.


Asunto(s)
Neoplasias de Cabeza y Cuello , Trabajadores Sociales , Estrés Psicológico , Neoplasias de Cabeza y Cuello/psicología , Humanos , Rol Profesional , Calidad de Vida , Factores de Riesgo , Apoyo Social
2.
J Genet Couns ; 20(3): 294-307, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21369831

RESUMEN

BRCA+ breast cancer patients face high risk for a second breast cancer and ovarian cancer. Helping these women decide among risk-reducing options requires effectively conveying complex, emotionally-laden, information. To support their decision-making needs, we developed a web-based decision aid (DA) as an adjunct to genetic counseling. Phase 1 used focus groups to determine decision-making needs. These findings and the Ottawa Decision Support Framework guided the DA development. Phase 2 involved nine focus groups of four stakeholder types (BRCA+ breast cancer patients, breast cancer advocates, and genetics and oncology professionals) to evaluate the DA's decision-making utility, information content, visual display, and implementation. Overall, feedback was very favorable about the DA, especially a values and preferences ranking-exercise and an output page displaying personalized responses. Stakeholders were divided as to whether the DA should be offered at-home versus only in a clinical setting. This well-received DA will be further tested to determine accessibility and effectiveness.


Asunto(s)
Neoplasias de la Mama/psicología , Técnicas de Apoyo para la Decisión , Genes BRCA1 , Genes BRCA2 , Tamización de Portadores Genéticos , Neoplasias de la Mama/genética , Neoplasias de la Mama/cirugía , Femenino , Grupos Focales , Asesoramiento Genético , Humanos , Mastectomía , Ovariectomía , Conducta de Reducción del Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA